(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.21%) $11.02
(0.56%) $0.808
(-0.95%) $93.01
-2.59% ¥ 2 148.00
Live Chart Being Loaded With Signals
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally...
Stats | |
---|---|
Today's Volume | 483 700 |
Average Volume | 430 850 |
Market Cap | 401.40B |
EPS | ¥0 ( 2024-02-07 ) |
Next earnings date | ( ¥38.32 ) 2024-05-13 |
Last Dividend | ¥29.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 13.25 |
ATR14 | ¥1.905 (0.09%) |
Volume Correlation
Alfresa Holdings Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Alfresa Holdings Correlation - Currency/Commodity
Alfresa Holdings Financials
Annual | 2022 |
Revenue: | ¥2 696.07B |
Gross Profit: | ¥192.09B (7.12 %) |
EPS: | ¥127.42 |
Q3 | 2023 |
Revenue: | ¥751.95B |
Gross Profit: | ¥55.07B (7.32 %) |
EPS: | ¥48.22 |
Q2 | 2023 |
Revenue: | ¥718.80B |
Gross Profit: | ¥51.41B (7.15 %) |
EPS: | ¥40.57 |
Q1 | 2023 |
Revenue: | ¥709.06B |
Gross Profit: | ¥47.82B (6.74 %) |
EPS: | ¥20.15 |
Financial Reports:
No articles found.
Alfresa Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥28.00 (N/A) |
¥0 (N/A) |
¥29.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥8.75 | 2006-03-28 |
Last Dividend | ¥29.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 36 | -- |
Total Paid Out | ¥544.25 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.32 | -- |
Div. Sustainability Score | 9.59 | |
Div.Growth Potential Score | 3.49 | |
Div. Directional Score | 6.54 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
4503.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3676.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
2930.T | Ex Dividend Junior | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
1812.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9369.T | Ex Dividend Junior | 2023-11-29 | Semi-Annually | 0 | 0.00% | |
8337.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
7722.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6881.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6254.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4971.T | Ex Dividend Junior | 2023-12-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0113 | 1.500 | 9.77 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0212 | 1.200 | 9.29 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0671 | 1.500 | -0.365 | -0.548 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.213 | 0.800 | 8.94 | 7.15 | [1 - 3] |
quickRatioTTM | 0.923 | 0.800 | 9.28 | 7.42 | [0.8 - 2.5] |
cashRatioTTM | 0.206 | 1.500 | 9.97 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0200 | -1.500 | 9.67 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 488.93 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 143.79 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 143.79 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0646 | -1.500 | 9.74 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0724 | 1.000 | -2.13 | -2.13 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0142 | 1.000 | -1.716 | -1.716 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.897 | 1.000 | 6.13 | 6.13 | [0.2 - 2] |
assetTurnoverTTM | 1.885 | 0.800 | 0.766 | 0.613 | [0.5 - 2] |
Total Score | 9.59 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 12.83 | 1.000 | 8.81 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0671 | 2.50 | -0.235 | -0.548 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 143.79 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.458 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 143.79 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.393 | 1.500 | -0.716 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00951 | 1.000 | -2.26 | 0 | [0.1 - 0.5] |
Total Score | 3.49 |
Alfresa Holdings
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators